Recurrence of acute anterior inflammation after intravitreal injection of bevacizumab in uveitis

Japanese Journal of Ophthalmology - Tập 53 - Trang 182-184 - 2009
Annabelle A. Okada1,2, Hiroshi Keino1, Takayo Watanabe1, Wakako Taki1, Ruriko Hayakawa1
1Kyorin Eye Center, Kyorin University School of Medicine, Tokyo, Japan
2Department of Ophthalmology, Kyorin University School of Medicine, Mitaka, Tokyo, Japan

Tài liệu tham khảo

Coma MC, Sobrin L, Onal S, et al. Intravitreal bevacizumab for treatment of uveitic macular edema. Ophthalmology 2007;114: 1574–1579. Ziemsson F, Deuter CM, Stuebiger N, Zierhut M. Weak transient response of chronic uveitic macular edema to intravitreal bevacizumab (Avastin). Graefes Arch Clin Exp Ophthalmol 2007;245: 917–918. Mackensen F, Heinz C, Becker MD, Heiligenhaus A. Intravitreal bevacizumab (Avastin) as a treatment for refractory macular edema in patients with uveitis. Retina 2008;28:41–45. Mansour AM, Mackensen F, Arevalo JF, et al. Intravitreal bevacizumab in inflammatory ocular neovascularization. Am J Ophthalmol 2008;146:410–416. Pieramici DJ, Avery RL, Castellarin AA, et al. Case of anterior uveitis after intravitreal injection of bevacizumab. Retina 2006; 26:841–842.